Publications by authors named "Maria Mavris"

Claim this Profile
T
The Added Value of Patient Engagement in Early Dialogue at EMA: Scientific Advice as a Case Study.
Aisling Murphy, Nathalie Bere, Spiros Vamvakas, Maria Mavris

Front Med (Lausanne)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engaging patients in medicines regulation: a tale of two agencies.
Maria Mavris, Andrea Furia Helms, Nathalie Bere

Nat Rev Drug Discov· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marketing authorisation of orphan medicines in Europe from 2000 to 2013.
Matthias P Hofer, Hanna Hedman, Maria Mavris, Franz Koenig, Thorsten Vetter

Drug Discov Today· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual Trade-Offs Between Possible Benefits and Risks of Cancer Treatments: Results from a Stated Preference Study with Patients with Multiple Myeloma.
Douwe Postmus, Sarah Richard, Nathalie Bere, Gert van Valkenhoef, Jayne Galinsky, Maria Mavris

Oncologist· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Animal models for metabolic, neuromuscular and ophthalmological rare diseases.
Guillaume Vaquer, Frida Rivière, Maria Mavris, Fabrizia Bignami, Jordi Llinares-Garcia

Nat Rev Drug Discov· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European regulation on orphan medicinal products: 10 years of experience and future perspectives.

Nat Rev Drug Discov· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Trw type IV secretion system of Bartonella mediates host-specific adhesion to erythrocytes.
Muriel Vayssier-Taussat, Danielle Le Rhun, Hong Kuan Deng, Francis Biville, Sandra Cescau, Maria Mavris

PLoS Pathog· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad-range PCR-TTGE for the first-line detection of bacterial pathogen DNA in ticks.
Lénaïg Halos, Maria Mavris, Gwenaël Vourc'h, Renaud Maillard, Jacques Barnouin

Vet Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of genes involved in long-term bacteremia in mice by Bartonella birtlesii.
Maria Mavris, Henri Saenz, Martine Monteil, Henri-Jean Boulouis, Christoph Dehio

Ann N Y Acad Sci· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A secreted anti-activator, OspD1, and its chaperone, Spa15, are involved in the control of transcription by the type III secretion apparatus activity in Shigella flexneri.
Claude Parsot, Elisabeth Ageron, Christophe Penno, Maria Mavris, Kais Jamoussi

Mol Microbiol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topological analysis of GtrA and GtrB proteins encoded by the serotype-converting cassette of Shigella flexneri.
Haralambos Korres, Maria Mavris, Renato Morona, Paul A Manning, Naresh K Verma

Biochem Biophys Res Commun· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of virulence plasmid gene expression defines three classes of effectors in the type III secretion system of Shigella flexneri.
Tony Le Gall, Maria Mavris, Maria Celeste Martino, Maria Lina Bernardini, Erick Denamur

Microbiology (Reading)· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbial-gut interactions in health and disease. Epithelial cell responses.
Maria Mavris, Philippe Sansonetti

Best Pract Res Clin Gastroenterol· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of the cis-acting site involved in activation of promoters regulated by activity of the type III secretion apparatus in Shigella flexneri.
Maria Mavris, Philippe J Sansonetti, Claude Parsot

J Bacteriol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus.
Maria Mavris, Anne-Laure Page, Régis Tournebize, Brigitte Demers, Philippe Sansonetti

Mol Microbiol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis